TAMMY CYR: Open Payments
NPI 1972926616 · TULLAHOMA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$504 in 29 payments from 8 companies in 2025. Trend: 2023 $460 · 2024 $422 · 2025 $504
Food & beverage: $504
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $155 |
| Axsome Therapeutics, Inc. | 5 | $85 |
| ABBVIE INC. | 3 | $63 |
| Otsuka America Pharmaceutical, Inc. | 3 | $54 |
| Neurocrine BioSciences, Inc. | 2 | $47 |
| Alkermes, Inc. | 2 | $43 |
| Lundbeck LLC | 2 | $35 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
Products named: CAPLYTA, Auvelity, VRAYLAR, INGREZZA, REXULTI, ABILIFY MAINTENA, ARISTADA, SPRAVATO.
Industry payments across TN — which companies pay providers there.
